Earnings calls

Artemis Medicare concall ledger

Every earnings call for ARTEMISMED — management tone, guidance, KPIs and promise tracking, quarter by quarter.

ARTEMISMED · 3 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 11 May 2026Call held 11 May 2026

ARTEMISMED Q4 FY26 Earnings Call Transcript & Analysis

FY26 Consolidated Revenue₹1,081 cr+15% YoYFY26 EBITDA₹218 crFY26 EBITDA Margin20.2%FY26 PAT₹104 cr+26% YoY

FY26 Consolidated Revenue ₹1,081 cr (+15% YoY); FY26 EBITDA ₹218 cr; FY26 EBITDA Margin 20.2%. FY26 consolidated revenue of ₹1,081 crores, up 15.4% YoY.

Read full transcript & analysis

Q3 FY26Published 03 Feb 2026Call held 03 Feb 2026

ARTEMISMED Q3 FY26 Earnings Call Transcript & Analysis

Revenue₹272 cr+17% YoYEBITDA₹52 crEBITDA Margin19.1%PAT₹22 cr+8% YoY

Revenue (Q3 FY26) ₹272 cr (+17% YoY); EBITDA (Q3 FY26) ₹52 cr; EBITDA Margin (Q3 FY26) 19.1%. Q3 FY26 Revenue from operations: INR 272 crores, 17.2% YoY growth.

Read full transcript & analysis

Q2 FY26Published 12 Nov 2025Call held 12 Nov 2025

ARTEMISMED Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹274.7 cr+14% YoYEBITDA₹58.3 crEBITDA Margin21.2%PAT₹30 cr+36% YoY

Revenue ₹275 cr (+14% YoY); EBITDA ₹58 cr; EBITDA Margin 21.2%. Consolidated revenue for Q2 FY26 was INR 274.7 crores, reflecting a 13.8% Y-o-Y growth.

Read full transcript & analysis